{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "20", "@year": "2019", "@timestamp": "2019-10-20T22:33:05.000005-04:00", "@month": "10"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "06"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding-addon-generated-timestamp": "2017-11-16T00:10:10.142Z", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacy Practice"}, {"$": "Faculty of Pharmaceutical Sciences"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113044315"}, "@dptid": "113044315"}, "author": [{"preferred-name": {"ce:given-name": "S.", "ce:initials": "S.", "ce:surname": "Vadcharavivad", "ce:indexed-name": "Vadcharavivad S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "PharmD BCP", "ce:surname": "Vadcharavivad", "@auid": "6506736554", "ce:indexed-name": "Vadcharavivad S."}, {"preferred-name": {"ce:given-name": "S.", "ce:initials": "S.", "ce:surname": "Praisuwan", "ce:indexed-name": "Praisuwan S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "MS", "ce:surname": "Praisuwan", "@auid": "57189439757", "ce:indexed-name": "Praisuwan S."}, {"preferred-name": {"ce:given-name": "W.", "ce:initials": "W.", "ce:surname": "Treyaprasert", "ce:indexed-name": "Treyaprasert W."}, "@seq": "4", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:degrees": "PhD", "ce:surname": "Treyaprasert", "@auid": "15844537100", "ce:indexed-name": "Treyaprasert W."}]}, {"affiliation": {"country": "Thailand", "@afid": "113483401", "@country": "tha", "city": "Bangkok", "organization": {"$": "Praram 9 Hospital"}, "affiliation-id": {"@afid": "113483401"}}, "author": [{"preferred-name": {"ce:given-name": "N.", "ce:initials": "N.", "ce:surname": "Techawathanawanna", "ce:indexed-name": "Techawathanawanna N."}, "@seq": "3", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Techawathanawanna", "@auid": "23487278700", "ce:indexed-name": "Techawathanawanna N."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425653"}, "@dptid": "104425653"}, "author": [{"preferred-name": {"ce:given-name": "Y.", "ce:initials": "Y.", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon Y."}, "@seq": "5", "ce:initials": "Y.", "@date-locked": "2018-07-27T21:17:03.882", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Avihingsanon", "@auid": "57196347321", "ce:indexed-name": "Avihingsanon Y."}]}, {"affiliation": {"country": "Thailand", "@afid": "60022183", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Excellence Center of Organ Transplantation"}, {"$": "King Chulalongkorn Memorial Hospital"}], "affiliation-id": {"@afid": "60022183", "@dptid": "114274357"}, "@dptid": "114274357"}, "author": [{"preferred-name": {"ce:given-name": "Y.", "ce:initials": "Y.", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon Y."}, "@seq": "5", "ce:initials": "Y.", "@date-locked": "2018-07-27T21:17:03.882", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Avihingsanon", "@auid": "57196347321", "ce:indexed-name": "Avihingsanon Y."}]}], "citation-title": "Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: Comparison with similar data from other populations", "abstracts": "\u00a9 2016 John Wiley & Sons Ltd.What is known and objective Tacrolimus, the most widely used calcineurin inhibitor in kidney transplantation, has a narrow therapeutic window with high interindividual variability in its pharmacokinetics. Clinically feasible models that combine important factors may help guide individual tacrolimus dosage adjustment in kidney transplant patients. The purpose of this study was to develop a population pharmacokinetic model and investigate the influence of clinical factors on the pharmacokinetics of tacrolimus in adult Thai kidney transplant patients from routine data monitoring. Methods A total of 1183 whole blood concentrations from 96 patients were characterized using nonlinear mixed-effects modelling. Clinical factors tested for influence on pharmacokinetic parameters were weight, haemoglobin, duration of tacrolimus therapy, prednisolone dose, serum albumin and estimated glomerular filtration rate. Results and discussion A one-compartment model with first-order absorption best described the data. The population estimate of tacrolimus apparent clearance (CL/F) and apparent volume of distribution (V/F) in the final population model was 21\u00b75 L/h (95% CI; 18\u00b738, 24\u00b734) and 333 L (95% CI; 222\u00b766, 484\u00b735), respectively. CL/F increased with decreasing haemoglobin levels and decreased with increasing duration of tacrolimus therapy (both P < 0\u00b7001). The population pharmacokinetic equation that predicted CL/F of tacrolimus was CL/F = 21\u00b75 \u00d7 exp (-0\u00b705 (HB - 11\u00b78)) \u00d7 (DOT/125)-0\u00b706, where CL/F was tacrolimus apparent oral clearance (L/h), HB was haemoglobin levels (g/dL), and DOT was duration of tacrolimus therapy (days). No covariates significantly influenced V/F. What is new and conclusion The first population pharmacokinetic model of tacrolimus in Thai adult kidney transplant patients was developed and validated. Haemoglobin and duration of tacrolimus therapy could partly explain the interindividual variability in the apparent clearance of tacrolimus. This manuscript also provides a summary review of previously reported population pharmacokinetic models of twice daily tacrolimus in adult kidney transplant recipients. Hemoglobin and duration of tacrolimus therapy could partly explain the interindividual variability of tacrolimus pharmacokinetics. A summary review of population pharmacokinetic models of twice daily tacrolimus in adult kidney transplant recipients is also provided.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacy Practice"}, {"$": "Faculty of Pharmaceutical Sciences"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:initials": "S.", "ce:degrees": "PharmD BCP", "ce:surname": "Vadcharavivad", "ce:indexed-name": "Vadcharavivad S."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "kidney transplantation", "@xml:lang": "eng"}, {"$": "Nonlinear Mixed Effect Model", "@xml:lang": "eng"}, {"$": "population pharmacokinetics", "@xml:lang": "eng"}, {"$": "tacrolimus", "@xml:lang": "eng"}, {"$": "therapeutic drug monitoring", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2710", "@type": "email"}}, "translated-sourcetitle": {"$": "Journal of Clinical Pharmacy and Therapeutics", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "41", "@issue": "3"}, "pagerange": {"@first": "310", "@last": "328"}}, "@type": "j", "sourcetitle": "Journal of Clinical Pharmacy and Therapeutics", "publicationdate": {"month": "06", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 June 2016"}, "day": "01"}, "codencode": "JCPTE", "sourcetitle-abbrev": "J. Clin. Pharm. Ther.", "@country": "gbr", "issn": [{"$": "13652710", "@type": "electronic"}, {"$": "02694727", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Blackwell Publishing Ltd", "ce:e-address": {"$": "customerservices@oxonblackwellpublishing.com", "@type": "email"}}, "@srcid": "23007"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "28", "classification-description": "Urology and Nephrology"}, {"classification-code": "30", "classification-description": "Clinical and Experimental Pharmacology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "9", "classification-description": "Surgery"}]}, {"@type": "ASJC", "classification": [{"$": "3004"}, {"$": "2736"}]}, {"@type": "SUBJABBR", "classification": [{"$": "PHAR"}, {"$": "MEDI"}]}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "9008-02-0", "chemical-name": "hemoglobin"}, {"cas-registry-number": "50-24-8", "chemical-name": "prednisolone"}, {"cas-registry-number": "9048-46-8", "chemical-name": "serum albumin"}, {"cas-registry-number": "104987-11-3", "chemical-name": "tacrolimus"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Calcineurin Inhibitors"}, {"chemical-name": "Hemoglobins"}, {"chemical-name": "Immunosuppressive Agents"}, {"chemical-name": "Prednisolone"}, {"chemical-name": "Tacrolimus"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2016 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "08", "@year": "2016", "@timestamp": "BST 15:49:16", "@month": "12"}}, "itemidlist": {"itemid": [{"$": "610544113", "@idtype": "PUI"}, {"$": "650942362", "@idtype": "CAR-ID"}, {"$": "20160403042", "@idtype": "EMBASE"}, {"$": "2016188456", "@idtype": "NURSNG"}, {"$": "20161263528", "@idtype": "REAXYSCAR"}, {"$": "84970998458", "@idtype": "SCP"}, {"$": "84970998458", "@idtype": "SGR"}, {"$": "615353429", "@idtype": "PUIsecondary"}, {"$": "27191538", "@idtype": "MEDL"}], "ce:doi": "10.1111/jcpt.12396"}}, "tail": {"bibliography": {"@refcount": "37", "reference": [{"ref-fulltext": "The Thai Transplant Society. Annual Report of Kidney Transplant in Thailand. 2013. Available at: http://www.transplantthai.org (accessed 14 October 2014).", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "http://www.transplantthai.org", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "84970978615", "@idtype": "SGR"}}, "ref-text": "The Thai Transplant Society. Available at: (accessed 14 October 2014)", "ref-sourcetitle": "Annual Report of Kidney Transplant in Thailand"}}, {"ref-fulltext": "Wallemacq P, Armstrong VW, Brunet M, et al,. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit, 2009; 31: 139-152.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference"}, "refd-itemidlist": {"itemid": {"$": "65349115890", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31"}, "pagerange": {"@first": "139", "@last": "152"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Wallemacq", "ce:indexed-name": "Wallemacq P."}, {"@seq": "2", "ce:initials": "V.W.", "@_fa": "true", "ce:surname": "Armstrong", "ce:indexed-name": "Armstrong V.W."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Brunet", "ce:indexed-name": "Brunet M."}], "et-al": null}, "ref-sourcetitle": "Ther Drug Monit"}}, {"ref-fulltext": "Pisitkun P, Eiam-Ong S, Praditpornsilpa K, Pansin P, Tungsanga K,. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients. Transplant Proc, 2002; 34: 3173-3175.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients"}, "refd-itemidlist": {"itemid": {"$": "0036905387", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "34"}, "pagerange": {"@first": "3173", "@last": "3175"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Pisitkun", "ce:indexed-name": "Pisitkun P."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Eiam-Ong", "ce:indexed-name": "Eiam-Ong S."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Praditpornsilpa", "ce:indexed-name": "Praditpornsilpa K."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Pansin", "ce:indexed-name": "Pansin P."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Tungsanga", "ce:indexed-name": "Tungsanga K."}]}, "ref-sourcetitle": "Transplant Proc"}}, {"ref-fulltext": "Venkataramanan R, Swaminathan A, Prasad T, et al,. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet, 1995; 29: 404-430.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "1995"}, "ref-title": {"ref-titletext": "Clinical pharmacokinetics of tacrolimus"}, "refd-itemidlist": {"itemid": {"$": "0029586398", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "404", "@last": "430"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Venkataramanan", "ce:indexed-name": "Venkataramanan R."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Swaminathan", "ce:indexed-name": "Swaminathan A."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Prasad", "ce:indexed-name": "Prasad T."}], "et-al": null}, "ref-sourcetitle": "Clin Pharmacokinet"}}, {"ref-fulltext": "Staatz C, Taylor P, Tett S,. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. Nephrol Dial Transplant, 2001; 16: 1905-1909.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation"}, "refd-itemidlist": {"itemid": {"$": "0034852733", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "1905", "@last": "1909"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Staatz", "ce:indexed-name": "Staatz C."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Taylor", "ce:indexed-name": "Taylor P."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Tett", "ce:indexed-name": "Tett S."}]}, "ref-sourcetitle": "Nephrol Dial Transplant"}}, {"ref-fulltext": "Kershner R, Fitzsimmons W,. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation, 1996; 62: 920-926.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-title": {"ref-titletext": "Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation"}, "refd-itemidlist": {"itemid": {"$": "0029849460", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "62"}, "pagerange": {"@first": "920", "@last": "926"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Kershner", "ce:indexed-name": "Kershner R."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Fitzsimmons", "ce:indexed-name": "Fitzsimmons W."}]}, "ref-sourcetitle": "Transplantation"}}, {"ref-fulltext": "Praditpornsilpa K, Townamchai N, Chaiwatanarat T, et al,. The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations. Nephrol Dial Transplant, 2011; 26: 2780-2785.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations"}, "refd-itemidlist": {"itemid": {"$": "79961058078", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26"}, "pagerange": {"@first": "2780", "@last": "2785"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Praditpornsilpa", "ce:indexed-name": "Praditpornsilpa K."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Townamchai", "ce:indexed-name": "Townamchai N."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Chaiwatanarat", "ce:indexed-name": "Chaiwatanarat T."}], "et-al": null}, "ref-sourcetitle": "Nephrol Dial Transplant"}}, {"ref-fulltext": "Lindbom L, Ribbing J, Jonsson E,. Perl-speaks-NONMEM (PsN)-a Perl module for NONMEM related programming. Comput Methods Programs Biomed, 2004; 75: 85-94.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Perl-speaks-NONMEM (PsN)-a Perl module for NONMEM related programming"}, "refd-itemidlist": {"itemid": {"$": "2942744625", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "75"}, "pagerange": {"@first": "85", "@last": "94"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Lindbom", "ce:indexed-name": "Lindbom L."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ribbing", "ce:indexed-name": "Ribbing J."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Jonsson", "ce:indexed-name": "Jonsson E."}]}, "ref-sourcetitle": "Comput Methods Programs Biomed"}}, {"ref-fulltext": "Bergstrand M, Hooker A, Wallin J, Karlsson M,. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effect models. AAPS J, 2011; 13: 143-151.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effect models"}, "refd-itemidlist": {"itemid": {"$": "79957451960", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "143", "@last": "151"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Bergstrand", "ce:indexed-name": "Bergstrand M."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hooker", "ce:indexed-name": "Hooker A."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wallin", "ce:indexed-name": "Wallin J."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Karlsson", "ce:indexed-name": "Karlsson M."}]}, "ref-sourcetitle": "AAPS J"}}, {"ref-fulltext": "Staatz C, Willis C, Taylor P, Tett S,. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Clin Pharmacol Ther, 2002; 72: 660-669.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Population pharmacokinetics of tacrolimus in adult kidney transplant recipients"}, "refd-itemidlist": {"itemid": {"$": "0036913473", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "72"}, "pagerange": {"@first": "660", "@last": "669"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Staatz", "ce:indexed-name": "Staatz C."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Willis", "ce:indexed-name": "Willis C."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Taylor", "ce:indexed-name": "Taylor P."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Tett", "ce:indexed-name": "Tett S."}]}, "ref-sourcetitle": "Clin Pharmacol Ther"}}, {"ref-fulltext": "Antignac M, Barrou B, Farinotti R, Lechat P, Urien S,. Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients. Br J Clin Pharmacol, 2007; 64: 750-757.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients"}, "refd-itemidlist": {"itemid": {"$": "36849058757", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "64"}, "pagerange": {"@first": "750", "@last": "757"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Antignac", "ce:indexed-name": "Antignac M."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Barrou", "ce:indexed-name": "Barrou B."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Farinotti", "ce:indexed-name": "Farinotti R."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Lechat", "ce:indexed-name": "Lechat P."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Urien", "ce:indexed-name": "Urien S."}]}, "ref-sourcetitle": "Br J Clin Pharmacol"}}, {"ref-fulltext": "Press R, Ploeger B, Hartigh J, et al,. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. Ther Drug Monit, 2009; 31: 187-197.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients"}, "refd-itemidlist": {"itemid": {"$": "65349104728", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31"}, "pagerange": {"@first": "187", "@last": "197"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Press", "ce:indexed-name": "Press R."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Ploeger", "ce:indexed-name": "Ploeger B."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hartigh", "ce:indexed-name": "Hartigh J."}], "et-al": null}, "ref-sourcetitle": "Ther Drug Monit"}}, {"ref-fulltext": "Benkali K, Premaud A, Picard N, et al,. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Clin Pharmacokinet, 2009; 48: 805-816.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients"}, "refd-itemidlist": {"itemid": {"$": "70449368823", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "48"}, "pagerange": {"@first": "805", "@last": "816"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Benkali", "ce:indexed-name": "Benkali K."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Premaud", "ce:indexed-name": "Premaud A."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Picard", "ce:indexed-name": "Picard N."}], "et-al": null}, "ref-sourcetitle": "Clin Pharmacokinet"}}, {"ref-fulltext": "Woillard J, Winter B, Kamar N, Marquet P, Rostaing L, Rousseau A,. Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations-twice daily Prograf\u00aeand once daily Advagraf\u00ae. Br J Clin Pharmacol, 2011; 71: 391-402.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations-twice daily Prograf\u00aeand once daily Advagraf\u00ae"}, "refd-itemidlist": {"itemid": {"$": "79251642984", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "71"}, "pagerange": {"@first": "391", "@last": "402"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Woillard", "ce:indexed-name": "Woillard J."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Winter", "ce:indexed-name": "Winter B."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kamar", "ce:indexed-name": "Kamar N."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Marquet", "ce:indexed-name": "Marquet P."}, {"@seq": "5", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Rostaing", "ce:indexed-name": "Rostaing L."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Rousseau", "ce:indexed-name": "Rousseau A."}]}, "ref-sourcetitle": "Br J Clin Pharmacol"}}, {"ref-fulltext": "Passey C, Birnbaum A, Brundage R, Oetting W, Israni A, Jacobson P,. Dosing equation for tacrolimus using genetic variants and clinical factors. Br J Clin Pharmacol, 2011; 72: 948-957.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Dosing equation for tacrolimus using genetic variants and clinical factors"}, "refd-itemidlist": {"itemid": {"$": "80855131391", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "72"}, "pagerange": {"@first": "948", "@last": "957"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Passey", "ce:indexed-name": "Passey C."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Birnbaum", "ce:indexed-name": "Birnbaum A."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Brundage", "ce:indexed-name": "Brundage R."}, {"@seq": "4", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Oetting", "ce:indexed-name": "Oetting W."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Israni", "ce:indexed-name": "Israni A."}, {"@seq": "6", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Jacobson", "ce:indexed-name": "Jacobson P."}]}, "ref-sourcetitle": "Br J Clin Pharmacol"}}, {"ref-fulltext": "Musuamba F, Mourad M, Haufroid V, et al,. A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic acid and tacrolimus early after renal transplantation. J Clin Pharmacol, 2012; 52: 1833-1843.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic acid and tacrolimus early after renal transplantation"}, "refd-itemidlist": {"itemid": {"$": "84868629996", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "1833", "@last": "1843"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Musuamba", "ce:indexed-name": "Musuamba F."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Mourad", "ce:indexed-name": "Mourad M."}, {"@seq": "3", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Haufroid", "ce:indexed-name": "Haufroid V."}], "et-al": null}, "ref-sourcetitle": "J Clin Pharmacol"}}, {"ref-fulltext": "Han N, Yun H, Hong J, et al,. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A genotype and clinical factors using NONMEM in adult kidney transplant recipients. Eur J Clin Pharmacol, 2013; 69: 53-63.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A genotype and clinical factors using NONMEM in adult kidney transplant recipients"}, "refd-itemidlist": {"itemid": {"$": "84872351222", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "69"}, "pagerange": {"@first": "53", "@last": "63"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Han", "ce:indexed-name": "Han N."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Yun", "ce:indexed-name": "Yun H."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hong", "ce:indexed-name": "Hong J."}], "et-al": null}, "ref-sourcetitle": "Eur J Clin Pharmacol"}}, {"ref-fulltext": "Zuo X, Ng C, Barrett J, et al,. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis. Pharmacogenet Genomics, 2013; 23: 251-261.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: A population pharmacokinetic analysis"}, "refd-itemidlist": {"itemid": {"$": "84876280783", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "251", "@last": "261"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Zuo", "ce:indexed-name": "Zuo X."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Ng", "ce:indexed-name": "Ng C."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Barrett", "ce:indexed-name": "Barrett J."}], "et-al": null}, "ref-sourcetitle": "Pharmacogenet Genomics"}}, {"ref-fulltext": "Ogasawara K, Chitnis SD, Gohh RY, Christians U, Akhlaghi F,. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. Clin Pharmacokinet, 2013; 52: 751-762.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients"}, "refd-itemidlist": {"itemid": {"$": "84883188340", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "751", "@last": "762"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ogasawara", "ce:indexed-name": "Ogasawara K."}, {"@seq": "2", "ce:initials": "S.D.", "@_fa": "true", "ce:surname": "Chitnis", "ce:indexed-name": "Chitnis S.D."}, {"@seq": "3", "ce:initials": "R.Y.", "@_fa": "true", "ce:surname": "Gohh", "ce:indexed-name": "Gohh R.Y."}, {"@seq": "4", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Christians", "ce:indexed-name": "Christians U."}, {"@seq": "5", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Akhlaghi", "ce:indexed-name": "Akhlaghi F."}]}, "ref-sourcetitle": "Clin Pharmacokinet"}}, {"ref-fulltext": "Han N, Ha S, Yun H, et al,. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. Basic Clin Pharmacol Toxicol, 2014; 114: 400-406.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation"}, "refd-itemidlist": {"itemid": {"$": "84897962292", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "114"}, "pagerange": {"@first": "400", "@last": "406"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Han", "ce:indexed-name": "Han N."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ha", "ce:indexed-name": "Ha S."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Yun", "ce:indexed-name": "Yun H."}], "et-al": null}, "ref-sourcetitle": "Basic Clin Pharmacol Toxicol"}}, {"ref-fulltext": "Golubovic B, Vucicevic K, Radivojevic D, Kovacevic SV, Prostran M, Miljkovic B,. Total plasma protein effect on tacrolimus elimination in kidney transplant patients- population pharmacokinetic approach. Eur J Pharm Sci, 2014; 52: 34-40.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Total plasma protein effect on tacrolimus elimination in kidney transplant patients- population pharmacokinetic approach"}, "refd-itemidlist": {"itemid": {"$": "84887585346", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "34", "@last": "40"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Golubovic", "ce:indexed-name": "Golubovic B."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Vucicevic", "ce:indexed-name": "Vucicevic K."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Radivojevic", "ce:indexed-name": "Radivojevic D."}, {"@seq": "4", "ce:initials": "S.V.", "@_fa": "true", "ce:surname": "Kovacevic", "ce:indexed-name": "Kovacevic S.V."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Prostran", "ce:indexed-name": "Prostran M."}, {"@seq": "6", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Miljkovic", "ce:indexed-name": "Miljkovic B."}]}, "ref-sourcetitle": "Eur J Pharm Sci"}}, {"ref-fulltext": "Storset E, Holford N, Midtvedt K, Bremer S, Bergan S, Asberg A,. Importance of hematocrit for a tacrolimus target concentration strategy. Eur J Clin Pharmacol, 2014; 70: 65-77.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Importance of hematocrit for a tacrolimus target concentration strategy"}, "refd-itemidlist": {"itemid": {"$": "84891867528", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "70"}, "pagerange": {"@first": "65", "@last": "77"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Storset", "ce:indexed-name": "Storset E."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Holford", "ce:indexed-name": "Holford N."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Midtvedt", "ce:indexed-name": "Midtvedt K."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Bremer", "ce:indexed-name": "Bremer S."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Bergan", "ce:indexed-name": "Bergan S."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Asberg", "ce:indexed-name": "Asberg A."}]}, "ref-sourcetitle": "Eur J Clin Pharmacol"}}, {"ref-fulltext": "Bergmann T, Henning S, Barraclough K, Isbel N, Staatz C,. Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose. Ther Drug Monit, 2014; 36: 62-70.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Population pharmacokinetics of tacrolimus in adult kidney transplant patients: Impact of CYP3A5 genotype on starting dose"}, "refd-itemidlist": {"itemid": {"$": "84892947151", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "36"}, "pagerange": {"@first": "62", "@last": "70"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Bergmann", "ce:indexed-name": "Bergmann T."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Henning", "ce:indexed-name": "Henning S."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Barraclough", "ce:indexed-name": "Barraclough K."}, {"@seq": "4", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Isbel", "ce:indexed-name": "Isbel N."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Staatz", "ce:indexed-name": "Staatz C."}]}, "ref-sourcetitle": "Ther Drug Monit"}}, {"ref-fulltext": "Storset E, Holford N, Hennig S, et al,. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. Br J Clin Pharmacol, 2014; 78: 509-523.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling"}, "refd-itemidlist": {"itemid": {"$": "84906500898", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "78"}, "pagerange": {"@first": "509", "@last": "523"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Storset", "ce:indexed-name": "Storset E."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Holford", "ce:indexed-name": "Holford N."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Hennig", "ce:indexed-name": "Hennig S."}], "et-al": null}, "ref-sourcetitle": "Br J Clin Pharmacol"}}, {"ref-fulltext": "Scholten EM, Cremers SC, Schoemaker RC, et al,. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients. Kidney Int, 2005; 67: 2440-2447.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients"}, "refd-itemidlist": {"itemid": {"$": "23044473459", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "67"}, "pagerange": {"@first": "2440", "@last": "2447"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.M.", "@_fa": "true", "ce:surname": "Scholten", "ce:indexed-name": "Scholten E.M."}, {"@seq": "2", "ce:initials": "S.C.", "@_fa": "true", "ce:surname": "Cremers", "ce:indexed-name": "Cremers S.C."}, {"@seq": "3", "ce:initials": "R.C.", "@_fa": "true", "ce:surname": "Schoemaker", "ce:indexed-name": "Schoemaker R.C."}], "et-al": null}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "Velickovic-Radovanovic R, Catic-Djordjevic A, Milovanovic JR, et al,. Population pharmacokinetics of tacrolimus in kidney transplant patients. Int J Clin Pharmacol Ther, 2010; 48: 375-382.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Population pharmacokinetics of tacrolimus in kidney transplant patients"}, "refd-itemidlist": {"itemid": {"$": "77952759759", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "48"}, "pagerange": {"@first": "375", "@last": "382"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Velickovic-Radovanovic", "ce:indexed-name": "Velickovic-Radovanovic R."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Catic-Djordjevic", "ce:indexed-name": "Catic-Djordjevic A."}, {"@seq": "3", "ce:initials": "J.R.", "@_fa": "true", "ce:surname": "Milovanovic", "ce:indexed-name": "Milovanovic J.R."}], "et-al": null}, "ref-sourcetitle": "Int J Clin Pharmacol Ther"}}, {"ref-fulltext": "Praisuwan S, Vadcharavivad S, Avihingsanon Y,. Hemoglobin levels influence pharmacokinetics of tacrolimus in kidney transplant patients. Thai Pharm Health Sci J, 2012; 7: 1-6.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Hemoglobin levels influence pharmacokinetics of tacrolimus in kidney transplant patients"}, "refd-itemidlist": {"itemid": {"$": "84970995960", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "1", "@last": "6"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Praisuwan", "ce:indexed-name": "Praisuwan S."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Vadcharavivad", "ce:indexed-name": "Vadcharavivad S."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon Y."}]}, "ref-sourcetitle": "Thai Pharm Health Sci J"}}, {"ref-fulltext": "Gandra SR, Finkelstein FO, Bennett AV, Lewis EF, Brazg T, Martin ML,. Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review. Am J Kidney Dis, 2010; 55: 519-534.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: A systematic review"}, "refd-itemidlist": {"itemid": {"$": "77049119917", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "55"}, "pagerange": {"@first": "519", "@last": "534"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Gandra", "ce:indexed-name": "Gandra S.R."}, {"@seq": "2", "ce:initials": "F.O.", "@_fa": "true", "ce:surname": "Finkelstein", "ce:indexed-name": "Finkelstein F.O."}, {"@seq": "3", "ce:initials": "A.V.", "@_fa": "true", "ce:surname": "Bennett", "ce:indexed-name": "Bennett A.V."}, {"@seq": "4", "ce:initials": "E.F.", "@_fa": "true", "ce:surname": "Lewis", "ce:indexed-name": "Lewis E.F."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Brazg", "ce:indexed-name": "Brazg T."}, {"@seq": "6", "ce:initials": "M.L.", "@_fa": "true", "ce:surname": "Martin", "ce:indexed-name": "Martin M.L."}]}, "ref-sourcetitle": "Am J Kidney Dis"}}, {"ref-fulltext": "Johansen KL, Finkelstein FO, Revicki DA, Gitlin M, Evans C, Mayne TJ,. Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents. Am J Kidney Dis, 2010; 55: 535-548.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents"}, "refd-itemidlist": {"itemid": {"$": "77049096460", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "55"}, "pagerange": {"@first": "535", "@last": "548"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.L.", "@_fa": "true", "ce:surname": "Johansen", "ce:indexed-name": "Johansen K.L."}, {"@seq": "2", "ce:initials": "F.O.", "@_fa": "true", "ce:surname": "Finkelstein", "ce:indexed-name": "Finkelstein F.O."}, {"@seq": "3", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Revicki", "ce:indexed-name": "Revicki D.A."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gitlin", "ce:indexed-name": "Gitlin M."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Evans", "ce:indexed-name": "Evans C."}, {"@seq": "6", "ce:initials": "T.J.", "@_fa": "true", "ce:surname": "Mayne", "ce:indexed-name": "Mayne T.J."}]}, "ref-sourcetitle": "Am J Kidney Dis"}}, {"ref-fulltext": "Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl, 2012; 2: 279-335.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "KDIGO clinical practice guideline for anemia in chronic kidney disease"}, "refd-itemidlist": {"itemid": {"$": "84884333035", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "279", "@last": "335"}}, "ref-text": "Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group", "ref-sourcetitle": "Kidney Int Suppl"}}, {"ref-fulltext": "Kurzawski M, Dro\u017adzik M,. Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs. Pharmacogenomics, 2013; 14: 1099-1118.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Pharmacogenetics in solid organ transplantation: Genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs"}, "refd-itemidlist": {"itemid": {"$": "84880476581", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "1099", "@last": "1118"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Kurzawski", "ce:indexed-name": "Kurzawski M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Dro\u017adzik", "ce:indexed-name": "Drozdzik M."}]}, "ref-sourcetitle": "Pharmacogenomics"}}, {"ref-fulltext": "Hesselink D, van Schaik R, van der Heiden I, et al,. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. Clin Pharmacol Ther, 2003; 74: 245-254.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus"}, "refd-itemidlist": {"itemid": {"$": "0041831261", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "74"}, "pagerange": {"@first": "245", "@last": "254"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Hesselink", "ce:indexed-name": "Hesselink D."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Van Schaik", "ce:indexed-name": "Van Schaik R."}, {"@seq": "3", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Van Der Heiden", "ce:indexed-name": "Van Der Heiden I."}], "et-al": null}, "ref-sourcetitle": "Clin Pharmacol Ther"}}, {"ref-fulltext": "Haufroid V, Mourad M, Kerckhove V, et al,. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Pharmacogenetics, 2004; 14: 147-154.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients"}, "refd-itemidlist": {"itemid": {"$": "12144286933", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "147", "@last": "154"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Haufroid", "ce:indexed-name": "Haufroid V."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Mourad", "ce:indexed-name": "Mourad M."}, {"@seq": "3", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Kerckhove", "ce:indexed-name": "Kerckhove V."}], "et-al": null}, "ref-sourcetitle": "Pharmacogenetics"}}, {"ref-fulltext": "Kuypers D, de Jonge H, Naesens M, Vanrenterghem Y,. A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients. Clin Ther, 2010; 32: 2012-2023.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients"}, "refd-itemidlist": {"itemid": {"$": "78649575551", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "2012", "@last": "2023"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Kuypers", "ce:indexed-name": "Kuypers D."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "De Jonge", "ce:indexed-name": "De Jonge H."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Naesens", "ce:indexed-name": "Naesens M."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Vanrenterghem", "ce:indexed-name": "Vanrenterghem Y."}]}, "ref-sourcetitle": "Clin Ther"}}, {"ref-fulltext": "MacPhee I, Holt D,. A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. Transplantation, 2008; 85: 163-165.", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype"}, "refd-itemidlist": {"itemid": {"$": "38549140495", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "85"}, "pagerange": {"@first": "163", "@last": "165"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.", "@_fa": "true", "ce:surname": "MacPhee", "ce:indexed-name": "MacPhee I."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Holt", "ce:indexed-name": "Holt D."}]}, "ref-sourcetitle": "Transplantation"}}, {"ref-fulltext": "Supanya D, Tassaneeyakul W, Sirivongs D, et al,. Prevalence of CYP3A5 polymorphism in a Thai population. Thai J Pharmacol, 2009; 31: 95-97.", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Prevalence of CYP3A5 polymorphism in a Thai population"}, "refd-itemidlist": {"itemid": {"$": "84883245788", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31"}, "pagerange": {"@first": "95", "@last": "97"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Supanya", "ce:indexed-name": "Supanya D."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Tassaneeyakul", "ce:indexed-name": "Tassaneeyakul W."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Sirivongs", "ce:indexed-name": "Sirivongs D."}], "et-al": null}, "ref-sourcetitle": "Thai J Pharmacol"}}, {"ref-fulltext": "Benkali K, Rostaing L, Premaud A, et al,. Population Pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation. Clin Pharmacokinet, 2010; 49: 683-692.", "@id": "37", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Population Pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation"}, "refd-itemidlist": {"itemid": {"$": "77956374555", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "49"}, "pagerange": {"@first": "683", "@last": "692"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Benkali", "ce:indexed-name": "Benkali K."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Rostaing", "ce:indexed-name": "Rostaing L."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Premaud", "ce:indexed-name": "Premaud A."}], "et-al": null}, "ref-sourcetitle": "Clin Pharmacokinet"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60022183", "affilname": "King Chulalongkorn Memorial Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "113483401", "affilname": "Praram 9 Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113483401", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84970998458", "dc:description": "What is known and objective Tacrolimus, the most widely used calcineurin inhibitor in kidney transplantation, has a narrow therapeutic window with high interindividual variability in its pharmacokinetics. Clinically feasible models that combine important factors may help guide individual tacrolimus dosage adjustment in kidney transplant patients. The purpose of this study was to develop a population pharmacokinetic model and investigate the influence of clinical factors on the pharmacokinetics of tacrolimus in adult Thai kidney transplant patients from routine data monitoring. Methods A total of 1183 whole blood concentrations from 96 patients were characterized using nonlinear mixed-effects modelling. Clinical factors tested for influence on pharmacokinetic parameters were weight, haemoglobin, duration of tacrolimus therapy, prednisolone dose, serum albumin and estimated glomerular filtration rate. Results and discussion A one-compartment model with first-order absorption best described the data. The population estimate of tacrolimus apparent clearance (CL/F) and apparent volume of distribution (V/F) in the final population model was 21\u00b75 L/h (95% CI; 18\u00b738, 24\u00b734) and 333 L (95% CI; 222\u00b766, 484\u00b735), respectively. CL/F increased with decreasing haemoglobin levels and decreased with increasing duration of tacrolimus therapy (both P < 0\u00b7001). The population pharmacokinetic equation that predicted CL/F of tacrolimus was CL/F = 21\u00b75 \u00d7 exp (-0\u00b705 (HB - 11\u00b78)) \u00d7 (DOT/125)-0\u00b706, where CL/F was tacrolimus apparent oral clearance (L/h), HB was haemoglobin levels (g/dL), and DOT was duration of tacrolimus therapy (days). No covariates significantly influenced V/F. What is new and conclusion The first population pharmacokinetic model of tacrolimus in Thai adult kidney transplant patients was developed and validated. Haemoglobin and duration of tacrolimus therapy could partly explain the interindividual variability in the apparent clearance of tacrolimus. This manuscript also provides a summary review of previously reported population pharmacokinetic models of twice daily tacrolimus in adult kidney transplant recipients. Hemoglobin and duration of tacrolimus therapy could partly explain the interindividual variability of tacrolimus pharmacokinetics. A summary review of population pharmacokinetic models of twice daily tacrolimus in adult kidney transplant recipients is also provided.", "pubmed-id": "27191538", "prism:coverDate": "2016-06-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84970998458", "dc:creator": {"author": [{"preferred-name": {"ce:given-name": "S.", "ce:initials": "S.", "ce:surname": "Vadcharavivad", "ce:indexed-name": "Vadcharavivad S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:degrees": "PharmD BCP", "ce:surname": "Vadcharavivad", "@auid": "6506736554", "author-url": "https://api.elsevier.com/content/author/author_id/6506736554", "ce:indexed-name": "Vadcharavivad S."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84970998458"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84970998458&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84970998458&origin=inward"}], "source-id": "23007", "citedby-count": "29", "prism:volume": "41", "subtype": "ar", "dc:title": "Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: Comparison with similar data from other populations", "openaccess": "1", "prism:issn": "13652710 02694727", "publishercopyright": "\u00a9 2016 John Wiley & Sons Ltd.", "prism:issueIdentifier": "3", "subtypeDescription": "Article", "prism:publicationName": "Journal of Clinical Pharmacy and Therapeutics", "prism:pageRange": "310-328", "prism:endingPage": "328", "openaccessFlag": "true", "prism:doi": "10.1111/jcpt.12396", "prism:startingPage": "310", "dc:identifier": "SCOPUS_ID:84970998458", "dc:publisher": "Blackwell Publishing Ltdcustomerservices@oxonblackwellpublishing.com"}, "idxterms": {"mainterm": [{"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Calcineurin Inhibitors", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Glomerular Filtration Rate", "@weight": "b", "@candidate": "n"}, {"$": "Hemoglobins", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Immunosuppressive Agents", "@weight": "b", "@candidate": "n"}, {"$": "Kidney Transplantation", "@weight": "a", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Models, Biological", "@weight": "a", "@candidate": "n"}, {"$": "Nonlinear Dynamics", "@weight": "b", "@candidate": "n"}, {"$": "Prednisolone", "@weight": "b", "@candidate": "n"}, {"$": "Tacrolimus", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}, {"$": "Tissue Distribution", "@weight": "b", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "kidney transplantation"}, {"@_fa": "true", "$": "Nonlinear Mixed Effect Model"}, {"@_fa": "true", "$": "population pharmacokinetics"}, {"@_fa": "true", "$": "tacrolimus"}, {"@_fa": "true", "$": "therapeutic drug monitoring"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmacology (medical)", "@code": "2736", "@abbrev": "MEDI"}]}, "authors": {"author": [{"preferred-name": {"ce:given-name": "S.", "ce:initials": "S.", "ce:surname": "Vadcharavivad", "ce:indexed-name": "Vadcharavivad S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:degrees": "PharmD BCP", "ce:surname": "Vadcharavivad", "@auid": "6506736554", "author-url": "https://api.elsevier.com/content/author/author_id/6506736554", "ce:indexed-name": "Vadcharavivad S."}, {"preferred-name": {"ce:given-name": "S.", "ce:initials": "S.", "ce:surname": "Praisuwan", "ce:indexed-name": "Praisuwan S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:degrees": "MS", "ce:surname": "Praisuwan", "@auid": "57189439757", "author-url": "https://api.elsevier.com/content/author/author_id/57189439757", "ce:indexed-name": "Praisuwan S."}, {"preferred-name": {"ce:given-name": "N.", "ce:initials": "N.", "ce:surname": "Techawathanawanna", "ce:indexed-name": "Techawathanawanna N."}, "@seq": "3", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "113483401", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113483401"}, "ce:degrees": "MD", "ce:surname": "Techawathanawanna", "@auid": "23487278700", "author-url": "https://api.elsevier.com/content/author/author_id/23487278700", "ce:indexed-name": "Techawathanawanna N."}, {"preferred-name": {"ce:given-name": "W.", "ce:initials": "W.", "ce:surname": "Treyaprasert", "ce:indexed-name": "Treyaprasert W."}, "@seq": "4", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:degrees": "PhD", "ce:surname": "Treyaprasert", "@auid": "15844537100", "author-url": "https://api.elsevier.com/content/author/author_id/15844537100", "ce:indexed-name": "Treyaprasert W."}, {"preferred-name": {"ce:given-name": "Y.", "ce:initials": "Y.", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon Y."}, "@seq": "5", "ce:initials": "Y.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}], "ce:degrees": "MD", "ce:surname": "Avihingsanon", "@auid": "57196347321", "author-url": "https://api.elsevier.com/content/author/author_id/57196347321", "ce:indexed-name": "Avihingsanon Y."}]}}}